Zelnorm is a drug owned by Alfasigma Usa Inc. It is protected by 1 US drug patent filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Apr 26, 2013. Details of Zelnorm's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
| US5510353 | Certain aminoguanidine compounds, pharmaceutical compositions containing them and their use in treating gastrointestinal motility disorders and disorders associated with cephalic pain |
Apr, 2013
(12 years ago) |
Expired
|
US patents provide insights into the exclusivity only within the United States, but
Zelnorm is protected by patents in multiple countries.
Understanding
the full scope
of patent protection is crucial in strategizing market entry. By looking at the broader patent
landscape, you can
identify markets with weaker patent protection which could be ideal generic entry points. The
following section offers
details on Zelnorm's family patents as well as insights into
ongoing legal events
on those patents.
Zelnorm's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Zelnorm's generic launch date based on the expiry of its last outstanding patent is estimated to be Apr 26, 2013 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Zelnorm Generics:
There are no approved generic versions for Zelnorm as of now.
About Zelnorm
Zelnorm is a drug owned by Alfasigma Usa Inc. It is used for managing symptoms of irritable bowel syndrome. Zelnorm uses Tegaserod Maleate as an active ingredient. Zelnorm was launched by Alfasigma in 2002.
Approval Date:
Zelnorm was approved by FDA for market use on 24 July, 2002.
Active Ingredient:
Zelnorm uses Tegaserod Maleate as the active ingredient. Check out other Drugs and Companies using Tegaserod Maleate ingredient
Treatment:
Zelnorm is used for managing symptoms of irritable bowel syndrome.
Dosage:
Zelnorm is available in tablet form for oral use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| EQ 2MG BASE | TABLET | Discontinued | ORAL |
| EQ 6MG BASE | TABLET | Discontinued | ORAL |